Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coppertone (BAY1183345) tolerability in adults with rosacea
NCT03841032Completed
- Sponsor
- Bayer
- Start
- Jan 2019
- Primary completion
- Feb 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of BAY987517 in rosacea, sponsored by Bayer. Primary endpoints: Number of subjects exhibiting increases in papules at 4 weeks, Number of subjects exhibiting increases in erythema at 4 weeks and 2 more. Started Jan 2019; status: completed.
02
Drugs
BAY987517
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03841032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03841032.